Edition:
India

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

7.15USD
2:29am IST
Change (% chg)

$-0.20 (-2.72%)
Prev Close
$7.35
Open
$7.30
Day's High
$7.35
Day's Low
$7.15
Volume
12,599
Avg. Vol
5,842
52-wk High
$9.20
52-wk Low
$5.05

Select another date:

Fri, Feb 9 2018

BRIEF-Chembio Diagnostics Announces Proposed Public Offering Of Common Stock

* CHEMBIO DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Chembio Diagnostics Announces Major New Tender Win And Certain Preliminary 2017 Financial Results

* CHEMBIO DIAGNOSTICS ANNOUNCES MAJOR NEW TENDER WIN AND CERTAIN PRELIMINARY 2017 FINANCIAL RESULTS

BRIEF-Chembio Diagnostics Appoints Neil Goldman As CFO

* CHEMBIO DIAGNOSTICS ANNOUNCES APPOINTMENT OF NEIL A. GOLDMAN AS CHIEF FINANCIAL OFFICER

BRIEF-Chembio Diagnostics And Astrazeneca Collaborates To Develop Point-Of-Care Diagnostic Test

* CHEMBIO DIAGNOSTICS AND ASTRAZENECA ENTER A COLLABORATION TO DEVELOP POINT-OF-CARE DIAGNOSTIC TEST

BRIEF-Chembio receives $8.5 mln commitment from Bio-Manguinhos to purchase components for production of dpp Assays in Brazil during 2018

* CHEMBIO RECEIVES $8.5 MILLION COMMITMENT FROM BIO-MANGUINHOS TO PURCHASE COMPONENTS FOR PRODUCTION OF DPP® ASSAYS IN BRAZIL DURING 2018

BRIEF-Chembio Diagnostics Awarded UNICEF Contract

* CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE DPP® ZIKA ASSAYS AND DPP® MICRO READERS

BRIEF-Chembio Diagnostics posts Q3 loss of $0.05 per share

* Chembio diagnostics reports third quarter 2017 financial results

BRIEF-Chembio Diagnostics CEO has returned to work after a medical leave of absence​

* Chembio Diagnostics Inc - president and CEO ‍John Sperzel has returned to work following a medical leave of absence​ Source text for Eikon: Further company coverage:

BRIEF-Chembio Diagnostics receives FDA emergency use authorization for the first rapid Zika Igm test

* Chembio Diagnostics receives FDA emergency use authorization for the first rapid Zika Igm test Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Select another date: